<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3262">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02018601</url>
  </required_header>
  <id_info>
    <org_study_id>ProsMaMa 13.1</org_study_id>
    <nct_id>NCT02018601</nct_id>
  </id_info>
  <brief_title>Intercostal Nerves Block in the Midaxillary Line Versus Paravertebral Block for no Reconstructive Breast Surgery</brief_title>
  <official_title>Intercostal Nerves Block in the Midaxillary Line Versus Paravertebral Block, Ultrasound Guided Blocks for no Reconstructive Breast Surgery. Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paula Diéguez García</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Complexo Hospitalario Universitario de A Coruña</source>
  <oversight_info>
    <authority>Spain: Spanish Agency of Medicines</authority>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objectives of the trial are the efficacy and safety of intercostal nerve block in
      the midaxillary line versus paravertebral block, both guided by ultrasound in patients
      scheduled for not reconstructive breast surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">September 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>pain score: verbal simple scale</measure>
    <time_frame>0,3,6,12,18 and 24h</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>admission to post-anesthesia care unit (PACU)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain score: visual number scale</measure>
    <time_frame>0, 3, 6,12, 18, 24h</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>post-admission to PACU</description>
  </primary_outcome>
  <primary_outcome>
    <measure>opioid requirements</measure>
    <time_frame>24 h</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>0 dose/ 1 dose/ 2 or more doses</description>
  </primary_outcome>
  <primary_outcome>
    <measure>sleep quality</measure>
    <time_frame>24 h</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>bad/regular/good</description>
  </primary_outcome>
  <primary_outcome>
    <measure>amount of sleep</measure>
    <time_frame>24 h</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>&lt; 3h/ 3-6h, &gt;6h</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>percentage of participants with nausea and vomiting</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>without symptoms/ nausea/vomiting/ both symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants with Serious and Non-Serious Adverse Events</measure>
    <time_frame>24 h</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>directly due to block nerve and general complications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>no Reconstructive Breast Surgery</condition>
  <arm_group>
    <arm_group_label>BRILMA&amp;dexketoprofen&amp;paracetamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>dexketoprofen: 50 mg/8h paracetamol: 1gr/6h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>paravertebral block&amp;dexketoprofen&amp;paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexketoprofen: 50 mg/8h paracetamol: 1g/6h</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>BRILMA</intervention_name>
    <arm_group_label>BRILMA&amp;dexketoprofen&amp;paracetamol</arm_group_label>
    <other_name>intercostal nerves block in the midaxillary line</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>paravertebral block</intervention_name>
    <arm_group_label>paravertebral block&amp;dexketoprofen&amp;paracetamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexketoprofen</intervention_name>
    <arm_group_label>BRILMA&amp;dexketoprofen&amp;paracetamol</arm_group_label>
    <arm_group_label>paravertebral block&amp;dexketoprofen&amp;paracetamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paracetamol</intervention_name>
    <arm_group_label>BRILMA&amp;dexketoprofen&amp;paracetamol</arm_group_label>
    <arm_group_label>paravertebral block&amp;dexketoprofen&amp;paracetamol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients scheduled for not reconstructive unilateral breast surgery.

          2. Physical status American Society Anesthesiologists (ASA) I-III.

          3. Signed informed consent.

          4. Aged between 18 and 75 years.

          5. Ability to assess pain using a verbal and numerical scales.

          6. Assessment of pain at the time of inclusion in the study is lower than 3 verbal
             simple scale

        Exclusion Criteria:

          1. Personal history of disorders of hemostasis or previous history of abnormal bleeding
             evidence.

          2. Local infection at the site of the puncture or to puncture prior systemic.

          3. Contraindications to study medication.

          4. Muscle or neurological disease, peripheral or central.

          5. Patients with prior history of opioid.

          6. Pregnancy or lactation.

          7. Difficulties in assessing pain or inability to understand or assist in the
             development of the study (psychiatric illness, cognitive impairments)

          8. Active Chronic alcoholism or drug addiction.

          9. BMI under 20 or mayor 30.

         10. Chronic treatment with non-steroidal anti-inflammatory drugs, antidepressants,
             anticonvulsants or opioids.

         11. Rejection of the patient
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Paula Diéguez, Anesthesiologist</last_name>
    <email>pauladieguez@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Abente y Lago. Complejo Hospitalario Universitario A Coruña</name>
      <address>
        <city>A Coruña</city>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paula Diéguez, Anesthesiologist</last_name>
      <email>pauladieguez@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Paula Diéguez, Anesthesiologist</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 17, 2013</lastchanged_date>
  <firstreceived_date>December 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Complexo Hospitalario Universitario de A Coruña</investigator_affiliation>
    <investigator_full_name>Paula Diéguez García</investigator_full_name>
    <investigator_title>anesthesiologist</investigator_title>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
